(P-1235) Should the Line for Linezolid be Less Zolid? Assessing the Safety and Tolerability of Linezolid for Durations of Therapy Greater than 14 Days

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Jessica Lai, PharmD (she/her/hers)

PGY2 Infectious Diseases Pharmacy Resident
University of Maryland Medical Center
Baltimore, MD, United States

Alexander R. Cain, PharmD, BCIDP

Clinical Pharmacy Specialist - Infectious Diseases/Antimicrobial Stewardship
University of Maryland Medical Center
Baltimore, Maryland, United States
Emily L. Heil, PharmD, MS

Professor
University of Maryland School of Pharmacy
Baltimore, MD, United States
JL

Jonathan S. Lapin, PharmD (he/him/his)

Clinical Pharmacy Specialist
University of Maryland Medical Center
Baltimore, Maryland, United States
SL

Sara Lee, PharmD

University of Maryland Medical Center
Baltimore, Maryland, United States
MB

Mandee Booth, PharmD, BCIDP

Assistant Professor
University of Maryland School of Pharmacy
Baltimore, Maryland, United States
RR

Ronald Rabinowitz, MD

Chief of Inf. Diseases R Adams Cowley Shock trauma Ctr
University of Maryland School of Medicine
baltimore, Maryland, United States
HS

Hyunuk Seung, MS

Statistician
University of Maryland School of Pharmacy
Baltimore, MD, United States